Renaissance announces GRAS notification for acrylamide-reducing yeast
31 August 2016 | By Roy Manuell, Digital Content Producer
Leading global yeast innovation company, Renaissance, is pleased to announce that the U.S. Food and Drug Administration (FDA) has “no questions”...